Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a thioredoxin-like 32 kda protein
Номер патента: EP1551866A1
Опубликовано: 13-07-2005
Автор(ы): David C. Anderson, Esteban Masuda, Justin E. Warner, Mark K. Bennett, Taisei Kinoshita, Todd M. Kinsella
Принадлежит: Rigel Pharmaceuticals Inc
Опубликовано: 13-07-2005
Автор(ы): David C. Anderson, Esteban Masuda, Justin E. Warner, Mark K. Bennett, Taisei Kinoshita, Todd M. Kinsella
Принадлежит: Rigel Pharmaceuticals Inc
Реферат: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a thioredoxin-like 32 kDa protein (TXNL) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
Номер патента: US20040014149A1. Автор: Esteban Masuda,David Anderson,Mark Bennett,Todd Kinsella,Taisei Kinoshita,Justin Warner. Владелец: Rigel Pharmaceuticals Inc. Дата публикации: 2004-01-22.